SEMNUR PHARMACEUTICALS INC (SMNR:OTCMKTS)
$0.72 0.01 (1.4085%)
Analysed SEMNUR PHARMACEUTICALS INC (SMNR:OTCMKTS) News Sources
Scilex Holding Company (“Scilex”) Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities with a Record Date of June 1, 2026
22-05-2026
yahoo.com
Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP
07-07-2026
yahoo.com
What is the current price of SEMNUR PHARMACEUTICALS INC (SMNR:OTCMKTS)?
The current price of SEMNUR PHARMACEUTICALS INC (SMNR:OTCMKTS) is $0.72.
SEMNUR PHARMACEUTICALS INC (SMNR:OTCMKTS) absolute price change since previous trading day?
The absolute price change of SEMNUR PHARMACEUTICALS INC (SMNR:OTCMKTS) since the previous trading day is $0.01.
SEMNUR PHARMACEUTICALS INC (SMNR:OTCMKTS) percentage price change since previous trading day?
The percentage price change of SEMNUR PHARMACEUTICALS INC (SMNR:OTCMKTS) since the previous trading day is 1.4085%.
What is the most recent average sentiment score for SEMNUR PHARMACEUTICALS INC (SMNR:OTCMKTS)?
The most recent average sentiment score for SEMNUR PHARMACEUTICALS INC (SMNR:OTCMKTS) is 80 out of 100.
What is the most recent average sentiment for SEMNUR PHARMACEUTICALS INC (SMNR:OTCMKTS)?
The most recent sentiment for SEMNUR PHARMACEUTICALS INC (SMNR:OTCMKTS) is .
SEC-8K** Filing Available For SEMNUR PHARMACEUTICALS INC (SMNR:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.